Rapid Dose Therapeutics Corp. (
CSE: DOSE,
Forum) announced today that it signed an amendment to expand on its recent 12 month distribution agreement with
Ukraine Pharma to distribute RDT’s QuickStrip products in Eastern Europe. The distribution agreement now numbers 11 total countries with a combined population of over 240 million people.
For more information on the amended agreement, click
here.
Earlier this week, the Canadian life sciences company
reported its financial results for Q1 2020. Highlights for the quarter included revenue recognition from QuickStrip nutraceutical product sales, QuickStrip distribution in Canada with
TFB & Associates Ltd., and a MOU with
Thrive Cannabis to sell QuickStrip technology using cannabis distillate in Canada
FULL DISCLOSURE: Rapid Dose Therapeutics Corp. is a client of Stockhouse Publishing.